📱 حمّل تطبيق خبر الآن! App Store Khabr Live
🕐 --:--
-- --
عاجل
⚡ عاجل: كريستيانو رونالدو يُتوّج كأفضل لاعب كرة قدم في العالم ⚡ أخبار عاجلة تتابعونها لحظة بلحظة على خبر ⚡ تابعوا آخر المستجدات والأحداث من حول العالم
⌘K
AI مباشر | -- مشاهد مباشر
1,083,774 مقال 401 مصدر نشط 228 قناة مباشرة 4,047 خبر اليوم
آخر تحديث: منذ 3 ثواني

More black men to benefit from prostate cancer screening trial

صحة
BBC Health
2026/06/02 - 14:41 517 مشاهدة
تحليل ذكي | AI Editorial Analysis

More black men to benefit from prostate cancer screening trial8 minutes agoShareSaveAdd as preferred on GooglePhilippa RoxbyHealth reporterGetty ImagesTens of thousands more black men aged 45-74 are t...

The move, announced by the government, has been welcomed by charities and campaigners as "a truly historic moment".

It comes as ministers have backed the UK National Screening Committee's recent recommendation that most men should not be offered regular testing for the disease.

هذا الخبر من BBC Health. خبر يقدم أدوات ذكاء اصطناعي للتلخيص والترجمة والاستماع.

More black men to benefit from prostate cancer screening trial8 minutes agoShareSaveAdd as preferred on GooglePhilippa RoxbyHealth reporterGetty ImagesTens of thousands more black men aged 45-74 are to be invited for prostate cancer checks as part of an ongoing trial in the UK to find better ways of testing for the disease. The move, announced by the government, has been welcomed by charities and campaigners as "a truly historic moment". It comes as ministers have backed the UK National Screening Committee's recent recommendation that most men should not be offered regular testing for the disease. The committee says the harms of using a blood test, called PSA, for screening outweigh the benefits in the majority of cases, except for "a few thousand" men who have a dangerous genetic variant and a family history of cancer. Men can talk to their doctor about whether a PSA (prostate specific antigen) test might be helpful. People should not ignore prostate symptoms, such as difficulty urinating. PSA test explainedBut while testing healthy men with no symptoms could save some lives, it would also lead to treatment that can leave men unable to control their bladder or have an erection. Some prostate tumours do not needed treating immediately and may never be life-threatening, which is part of why widespread screening is not being recommended. Prostate cancer is the most common cancer in men in the UK, with 64,000 men diagnosed and 12,000 dying each year. One in eight men will get prostate cancer in their lifetime and for black men, that risk doubles to one in four. The goverment says it will invest £18 million into the TRANSFORM trial so that more black men will be invited to take part in the research. The trial is assessing whether extra tests alongside PSA, such genetic checks and MRI scans, can improve screening accuracy. All black men aged 45-74 who have not already had a recent PSA test will be offered the chance to participate. The government says the trial will help build a more effective screening system for the disease for the future. "This is a major step forward in how we tackle prostate cancer - focusing on those most at risk, improving the treatments available, and backing the research we need to close the evidence gaps and save lives," said Health Secretary James Murray. The trial started inviting men earlier this year. It will test new, cutting-edge screening techniques such as fast MRI scans and genetic spit tests to find the best ways to detect the disease. Prostate Cancer UK said it was "delighted" by the government's decision, which would help the charity reach more black men "with clear, trusted information". Prostate cancer screening only for 'a few thousand' high risk menProstate cancer screening: What you need to knowWhat are the symptoms of prostate cancer and what should you check for?Cancer screeningCancerHealthProstate cancer
المصدر: BBC Health | Source: BBC Health

ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة BBC Health. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.

This article was originally published by BBC Health. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.

مشاركة:

المزيد عن صحة | More on Health

هذا الخبر ضمن تغطية خبر لقسم صحة. نقدّم لك تحليلات ذكية وملخصات يومية لأهم الأخبار من مصادر موثوقة متعددة. المصدر: BBC Health. يوجد 6 مقالات مرتبطة بهذا الموضوع.

This article is part of Khabr's coverage of Health. We provide AI-powered analysis, summaries, and multi-source aggregation to keep you informed. Source: BBC Health. Tags: سرطان البروستاتا, تجربة, رجال سود.

مقالات ذات صلة

خبر — منصة إخبارية ذكية | Khabr — AI-Powered News Platform

خبر هو أول مجمّع أخبار عربي يعمل بالذكاء الاصطناعي. نقدم تحليلات ذكية وملخصات تلقائية ورواية صوتية لكل خبر من أكثر من 700 مصدر موثوق. نضيف قيمة تحريرية فريدة من خلال أدوات الذكاء الاصطناعي التي تساعدك على فهم الأخبار بعمق أكبر.

Khabr is the first AI-powered Arabic news aggregator. We provide AI-generated editorial analysis, automated summaries, audio narration, and fact-checking for every article from 700+ trusted sources. Our platform adds unique editorial value through AI tools that help you understand the news more deeply.

AI
يا هلا! اسألني أي شي 🎤
🔍
FREE Free 1GB Internet + Free International Calls

$1 trial — eSIM in 190+ countries — No roaming charges

Download Free